Literature DB >> 7909058

Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL Group.

P Fenaux, C Chastang, C Chomienne, L Degos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909058     DOI: 10.1016/s0140-6736(94)90151-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Arsenic inhibition of telomerase transcription leads to genetic instability.

Authors:  W C Chou; A L Hawkins; J F Barrett; C A Griffin; C V Dang
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Retinoic acid syndrome. Recognition, prevention and management.

Authors:  P Fenaux; S De Botton
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

Review 3.  Clinical pharmacokinetics of tretinoin.

Authors:  M B Regazzi; I Iacona; C Gervasutti; M Lazzarino; S Toma
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

Review 4.  Acute promyelocytic leukaemia: novel insights into the mechanisms of cure.

Authors:  Hugues de Thé; Zhu Chen
Journal:  Nat Rev Cancer       Date:  2010-10-22       Impact factor: 60.716

Review 5.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

Review 6.  History of Acute Promyelocytic Leukemia.

Authors:  Miguel A Sanz; Eva Barragán
Journal:  Clin Hematol Int       Date:  2021-07-19

7.  Induction treatments for acute promyelocytic leukemia: a network meta-analysis.

Authors:  Junjie Huang; Min Sun; Zitong Wang; Qiaoxia Zhang; Jin Lou; Yun Cai; Weihong Chen; Xin Du
Journal:  Oncotarget       Date:  2016-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.